LEADER 03413nam  22005894a 450 
001 9910809954803321
005 20200520144314.0
010   $a1-281-32054-4
010   $a9786611320546
010   $a0-470-75595-4
010   $a0-470-75521-0
035   $a(CKB)1000000000399542
035   $a(EBL)351431
035   $a(OCoLC)437218682
035   $a(SSID)ssj0000244588
035   $a(PQKBManifestationID)11240367
035   $a(PQKBTitleCode)TC0000244588
035   $a(PQKBWorkID)10171204
035   $a(PQKB)11327255
035   $a(MiAaPQ)EBC351431
035   $a(Au-PeEL)EBL351431
035   $a(CaPaEBR)ebr10232857
035   $a(CaONFJC)MIL132054
035   $a(EXLCZ)991000000000399542
100   $a20041217d2005      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aSevere acute respiratory syndrome /$fedited by Malik Peiris ... [et al.]
205   $a1st ed.
210   $aMalden, Mass $cBlackwell Pub.$d2005
215   $a1 online resource (286 p.)
300   $aDescription based upon print version of record.
311   $a1-4051-3031-8 
320   $aIncludes bibliographical references and index.
327   $aSevere Acute Respiratory Syndrome; Contents; Contributors; Foreword; Acknowledgements; 1. SARS: A Historical Perspective from Hong Kong; 2. SARS: A Global Perspective; 3. Clinical Presentation of the Disease in Adults; 4. SARS in Children; 5. SARS: Sequelae and Implications for Rehabilitation; 6. Radiology of SARS; 7. Aetiology of SARS; 8. Structure of the Genome of SARS CoV; 9. Viral Diagnosis of SARS; 10. Pathology and Pathogenesis; 11. SARS Coronavirus: An Animal Reservoir?; Colour plate facing page 80; 12. Comparative Biology of Animal Coronaviruses: Lessons for SARS
327   $a13. Epidemiology and Transmission of SARS14. Transmission Dynamics and Control of the Viral Aetiological Agent of SARS; 15. The Seasonality of Respiratory Virus Diseases: Implications for SARS?; 16. Public Health Response: A View from Singapore; 17. Public Health Response: A View from Hong Kong; 18. Public Health Response: A View from a Region with a Low Incidence of SARS; 19. Infection Control for SARS: Causes of Success and Failure; 20. Antiviral Agents for SARS; 21. Vaccines; 22. Counting the Economic Cost of SARS; 23. Preparing for a Possible Resurgence of SARS
327   $a24. Lessons for the Future: Pandemic Influenza25. Lessons Learnt; Appendix; Index
330   $aPrompting the first WHO global health alert for over a decade, Severe Acute Respiratory Syndrome (SARS) was first recognised in South-East Asia in February 2003.  With the causative agent now identified as a new strain of coronavirus, the medical world has gained important knowledge on the aetiology, clinical presentation, diagnosis, pathogenesis, epidemiology, disease treatment and infection control with amazing speed.  Despite this, major gaps remain in our understanding - the race is on to develop new cures and effective vaccines, and the long-term impact on health, society and 
606   $aSARS (Disease)
615  0$aSARS (Disease)
676   $a616.2
701   $aPeiris$b Malik$0864866
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910809954803321
996   $aSevere acute respiratory syndrome$91930429
997   $aUNINA